BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 35249870)

  • 1. [TRIM21 suppresses invasion of hepatocellular carcinoma cells by promoting β-catenin ubiquitylation and degradation].
    Zhang Z; Zhu Z; Sheng H; Sun J; Cao C
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):55-62. PubMed ID: 35249870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway.
    Wan B; Cheng M; He T; Zhang L
    BMC Cancer; 2024 May; 24(1):618. PubMed ID: 38773433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway.
    Shu B; Zhou Y; Lei G; Peng Y; Ding C; Li Z; He C
    Cancer Sci; 2024 May; 115(5):1476-1491. PubMed ID: 38475938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt/β-catenin pathway.
    Li S; Wang J; Chen H; Hou J; Shen T; Li J; Zhou B; Zhang B; Liu H; Jiang DK
    Mol Carcinog; 2023 Nov; 62(11):1686-1699. PubMed ID: 37477507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells.
    Long G; Wu Z; Wang D; Mi X; Hu K; Zhou L; Tang J
    Free Radic Biol Med; 2024 Feb; 212():162-173. PubMed ID: 38092274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.
    Wang K; Wu J; Yang Z; Zheng B; Shen S; Wang RR; Zhang Y; Wang HY; Chen L; Qiu X
    Cancer Lett; 2024 Apr; 586():216690. PubMed ID: 38307410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of peroxiredoxin 2 suppresses proliferation and Wnt/β-catenin pathway, and induces senescence in hepatocellular carcinoma.
    Yang X; Xiang X; Xu G; Zhou S; An T; Huang Z
    Oncol Res; 2023; 32(1):213-226. PubMed ID: 38188679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP90, as a functional target antigen of a mAb 11C9, promotes stemness and tumor progression in hepatocellular carcinoma.
    Liu HQ; Sun LX; Yu L; Liu J; Sun LC; Yang ZH; Shu X; Ran YL
    Stem Cell Res Ther; 2023 Sep; 14(1):273. PubMed ID: 37759328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The deubiquitinase USP7 and E3 ligase TRIM21 regulate vasculogenic mimicry and malignant progression of RMS by balancing SNAI2 homeostasis.
    Zhang R; Zhang D; Han F; Song X; Zhang Y; Zhang J; Zhu Q; Qin Y
    J Exp Clin Cancer Res; 2024 May; 43(1):135. PubMed ID: 38702792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma.
    Li Y; Bao L; Zheng H; Geng M; Chen T; Dai X; Xiao H; Yang L; Mao C; Qiu Y; Xu Y; Wang D; Li MX; Chen Q
    Theranostics; 2023; 13(14):4919-4935. PubMed ID: 37771771
    [No Abstract]   [Full Text] [Related]  

  • 11. N
    Wei H; Huang L; Lu Q; Huang Z; Huang Y; Xu Z; Li W; Pu J
    J Hepatocell Carcinoma; 2023; 10():1991-2007. PubMed ID: 37954496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High expression of UBE2S promotes progression of hepatocellular carcinoma by increasing cancer cell stemness].
    Chen H; Li Z; Wang M; Lu L; Tang Q; Luo L
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):455-464. PubMed ID: 38597436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma.
    Yang Y; Zuo S; Li W; Di M; Liu J; Chai J; Wang J; Yuan Y; Li M; Jia Q
    Pathol Res Pract; 2023 Aug; 248():154710. PubMed ID: 37494805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of
    Lu G; Lin J; Song G; Chen M
    Aging (Albany NY); 2023 Sep; 15(18):9759-9778. PubMed ID: 37733676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic dependency on β-catenin in liver cancer cell lines correlates with pathway activation.
    Ding Z; Shi C; Jiang L; Tolstykh T; Cao H; Bangari DS; Ryan S; Levit M; Jin T; Mamaat K; Yu Q; Qu H; Hopke J; Cindhuchao M; Hoffmann D; Sun F; Helms MW; Jahn-Hofmann K; Scheidler S; Schweizer L; Fang DD; Pollard J; Winter C; Wiederschain D
    Oncotarget; 2017 Dec; 8(70):114526-114539. PubMed ID: 29383099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Development in Hepatocytes by Long-Term Induction of Hypoxic Hepatocellular Carcinoma Cell (HCC)-Derived Exosomes
    Ju T; Dong J; Wang B; Qu K; Cheng C; He X; Tian Y; Crabbe MJC; Wang Z; Chen Y
    Mol Pharm; 2023 Nov; 20(11):5579-5592. PubMed ID: 37844208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 - β-catenin cascade to promote liver tumorigenesis.
    Sinha S; Aizawa S; Nakano Y; Rialdi A; Choi HY; Shrestha R; Pan SQ; Chen Y; Li M; Kapelanski-Lamoureux A; Yochum G; Sher L; Monga SP; Lazaris A; Machida K; Karin M; Guccione E; Tsukamoto H
    Nat Commun; 2023 May; 14(1):2651. PubMed ID: 37156770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous beta-catenin activation is sufficient to cause hepatocellular carcinoma in zebrafish.
    Kalasekar SM; Kotiyal S; Conley C; Phan C; Young A; Evason KJ
    Biol Open; 2019 Oct; 8(10):. PubMed ID: 31575545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer.
    Wu Z; Zhang J; Jia Z; Yang Z; Liu S; Wang H; Zhao C; Zhao J; Tang Q; Xiong Y; Yang Y; Zhang Y; Zhou Z; Yue J; Xiao F; Sun Q; Gong A; Yao W; Li H; Song X; Ye Y; Zhu Y; Dong P; Ma F; Wu X; Gong W
    Cancer Lett; 2024 May; 592():216923. PubMed ID: 38697462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral infection and spread are inhibited by the polyubiquitination and downregulation of TRPV2 channel by the interferon-stimulated gene TRIM21.
    Guo YY; Gao Y; Zhao YL; Xie C; Gan H; Cheng X; Yang LP; Hu J; Shu HB; Zhong B; Lin D; Yao J
    Cell Rep; 2024 Apr; 43(4):114095. PubMed ID: 38613787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.